Home » Rheumatoid Arthritis Symptoms » Juvenile Rheumatoid Arthritis Symptoms
Juvenile Rheumatoid Arthritis Symptoms
Enbrel: FDA Approval In The Treatment Of Juvenile Rheumatoid Arthritis
For children, under age 16, who suffer from arthritic related symptoms greater than six weeks, the complication is often believed to be attributed to the development of juvenile rheumatoid arthritis. Each year, many children are diagnosed with this life changing condition. As parents, understanding the use of the FDA approved drug, Enbrel, in the treatment of juvenile rheumatoid arthritis, the side effects, dosing and the contraindications, may provide for a more educated process when determining the method or route of healthcare to be administered to your child.
Enbrel, manufactured by Immunex Corporation, is an FDA approved drug used to treat the symptoms associated with active juvenile rhuematoid arthritis including the associated joint and physiological deterioration. Lending its primary success to the reduction of inflammation, swelling and tenderness in joints, Enbrel may be the key injection to reducing significant pain factors associated with juvenile rheumatoid arthritis thereby increasing joint movement and mobility in children. As with any childhood disorder, diagnosing the condition early and administering aggressive treatment, may ensure the most optimal outcome. As an injection, Enbrel is administered in children suffering from juvenile rheumatoid arthritis once or twice weekly at a dosing level of 0.4 milligrams of drug per kilogram of child body weight. The maximum dosing, however, is subject to the recommended adult dosing of 25 milligrams per injection. The benefit of Enbrel, following adminstration of the injection, can be seen as early as two weeks with benefits continuing up to three months. As with any prescribed medication, Enbrel does come with side effects and contraindications in the treatment of juvenile rheumatoid arthritis. For children suffering from juvenile rheumatoid arthritis, comorbid for central nervous system disorders, Enbrel is not an appropriate form of treatment. Additionally, for teenage girls who may be sexually active, Enbrel should not be used due to the lack of research in the health implicattions Enbrel may have on a fetus. Additionally, Enbrel, in the treatment of juvenile rheumatoid arthritis, may impede the heaing process of wounds. As a result, Enbrel, is contraindicated in patients comorbid with diabetes or in patients with a general compromised immune system due to immunosuppressive diseases. For children suffering from juvenile rheumatoid arthritis, obtaining symptom relief is a primary concern for both parents as well as healthcare professionals. With the introduction of Enbrel, once or twice weekly, statistics have shown three out of four juvenile rheumatoid arthritis children will not only experience relief of symptoms but will obtain benefits in improved structural bone improvement. With the administration of Enbrel, twice weekly, juvenile rheumatoid arthritis associated symptoms are alleviated allowing the child to return to activities of daily living. For more information regarding the use of Enbrel in the treatment of juvenile rheumatoid arthritis, visit www.enbrel.com.By Christine Cadena - SEO web content developer, link building strategist, and expert in both onpage and offpage SEO. Need any of these services? Contact me here at AC.
Juvenile Rheumatoid Arthritis Symptoms, What Do You Experien
31 Oct 2009 at 7:20am
Next page: Rheumatoid Arthritis Symptoms
Bookmark/Share This Page:
|
|
|
|
Juvenile Rheumatoid Arthritis Symptoms News
May is arthritis awareness month
21 May 2012 at 11:20am While it may not be seen as a traditional disability, Arthritis is the leading cause of disability in the U.S. According to the Arthritis Foundation , May is Arthritis Awareness Month.Read more...
Go for a walk in Davis Bay
27 Apr 2012 at 2:11am The Sunshine Coast Akroswirls were at Trail Bay Mall recently giving out information on lupus, sjogren, scleroderma, Raynaud?s disease, rheumatoid arthritis, multiple sclerosis and juvenile diabetes, all of which belong to the same family of diseases.Read more...
Arthritis Foundation spring fundraisers are April 26, 28
24 Apr 2012 at 1:45pm MOBILE, Alabama -- On April 26, the Arthritis Foundation will host its second annual spring-themed dinner fundraiser at Camp Grace in west Mobile. "It's not a black-tie event," said Kellie Myers, regional director of development services for the Arthritis Foundation. "It's fun, not stuffy."Read more...
